DURASON

Waren und Dienstleistungen

5 Describing and providing medical diagnostic and pharmaceutical preparations with anti-sense oligonucleotides for testing, preventing, and therapeutically treating human and non-human animal respiratory ailments that may be associated with hyper-sensitivity or hyper-responsiveness to adenosine, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in many cases are adenosine receptor associated symptoms; pharmaceutical preparations for the treatment of airway and pulmonary diseases and conditions, such as asthma, pulmonary vascoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vascoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, hepatic metastases, etc., as well as all other metastatic cancers, e.g., cancers which metastasized to the lung(s), breast, liver and prostate

Übersetzung anzeigen

Markenform	Wortmarke
Aktenzeichen	76113584
Registernummer	2611635

Anmeldedatum	16. August 2000
Veröffentlichungsdatum	04. Juni 2002
Eintragungsdatum	27. August 2002

Schützen Sie diese Marke vor Nachahmern!

Markendetails Letztes Update: 16. Mai 2018

Markeninhaber

Markenvertreter

Waren und Dienstleistungen